Polymeric Nanocapsules As Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities

Overview

Journal Nanomaterials (Basel)

Date 2020 May 2

PMID 32354008

Citations 70

Authors

Siyuan Deng

Maria Rosa Gigliobianco

Roberta Censi

Piera Di Martino

Affiliations

Soon will be listed here.

Abstract

Polymer-based nanocapsules have been widely studied as a potential drug delivery system in recent years. Nanocapsules-as one of kind nanoparticle-provide a unique nanostructure, consisting of a liquid/solid core with a polymeric shell. This is of increasing interest in drug delivery applications. In this review, nanocapsules delivery systems studied in last decade are reviewed, along with nanocapsule formulation, characterizations of physical/chemical/biologic properties and applications. Furthermore, the challenges and opportunities of nanocapsules applications are also proposed.

Citing Articles

Nanomedicine and Its Role in Surgical Wound Infections: A Practical Approach.

Bentaleb M, Abdulrahman M, Ribeiro Jr M Bioengineering (Basel). 2025; 12(2).

PMID: 40001657 PMC: 11852320. DOI: 10.3390/bioengineering12020137.

Photodynamic therapy for the precise treatment of localized prostate cancer.

Xu Y, Tan Q, Sun C, Jia Y, Li S, Yang X Front Oncol. 2025; 15:1454392.

PMID: 39975598 PMC: 11835664. DOI: 10.3389/fonc.2025.1454392.

Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges.

Wang M, Yu F, Zhang Y Mol Cancer. 2025; 24(1):26.

PMID: 39827147 PMC: 11748575. DOI: 10.1186/s12943-024-02214-5.

Nanomedicine embraces the treatment and prevention of acute kidney injury to chronic kidney disease transition: evidence, challenges, and opportunities.

Li J, Duan J, Hua C, Pan S, Li G, Feng Q Burns Trauma. 2024; 12:tkae044.

PMID: 39678075 PMC: 11645459. DOI: 10.1093/burnst/tkae044.

Biopharmaceutical and pharmacokinetic attributes to drive nanoformulations of small molecule tyrosine kinase inhibitors.

Mukherjee S, Joshi V, Reddy K, Singh N, Das P, Datta P Asian J Pharm Sci. 2024; 19(6):100980.

PMID: 39640056 PMC: 11617995. DOI: 10.1016/j.ajps.2024.100980.

References

Haznedar S, Dortunc B . Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide. Int J Pharm. 2003; 269(1):131-40. DOI: 10.1016/j.ijpharm.2003.09.015. View

DeFrates K, Markiewicz T, Gallo P, Rack A, Weyhmiller A, Jarmusik B . Protein Polymer-Based Nanoparticles: Fabrication and Medical Applications. Int J Mol Sci. 2018; 19(6). PMC: 6032199. DOI: 10.3390/ijms19061717. View

Jain K . Nanodiagnostics: application of nanotechnology in molecular diagnostics. Expert Rev Mol Diagn. 2003; 3(2):153-61. DOI: 10.1586/14737159.3.2.153. View

Ismail M, Du Y, Ling L, Li X . Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria. Int J Pharm. 2019; 562:162-171. DOI: 10.1016/j.ijpharm.2019.03.031. View

Fu C, Ding C, Sun X, Fu A . Curcumin nanocapsules stabilized by bovine serum albumin-capped gold nanoclusters (BSA-AuNCs) for drug delivery and theranosis. Mater Sci Eng C Mater Biol Appl. 2018; 87:149-154. DOI: 10.1016/j.msec.2017.12.028. View

Menard M, Meyer F, Parkhomenko K, Leuvrey C, Francius G, Begin-Colin S . Mesoporous silica templated-albumin nanoparticles with high doxorubicin payload for drug delivery assessed with a 3-D tumor cell model. Biochim Biophys Acta Gen Subj. 2018; 1863(2):332-341. DOI: 10.1016/j.bbagen.2018.10.020. View

Xia X, Hu Z, Marquez M . Physically bonded nanoparticle networks: a novel drug delivery system. J Control Release. 2005; 103(1):21-30. DOI: 10.1016/j.jconrel.2004.11.016. View

Chen H, Wang L, Yeh J, Wu X, Cao Z, Wang Y . Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PgammaMPS copolymer coating. Biomaterials. 2010; 31(20):5397-407. PMC: 2878482. DOI: 10.1016/j.biomaterials.2010.03.036. View

Boissenot T, Fattal E, Bordat A, Houvenagel S, Valette J, Chacun H . Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents. Eur J Pharm Biopharm. 2016; 108:136-144. DOI: 10.1016/j.ejpb.2016.08.017. View

10.

Lukasiewicz S, Szczepanowicz K, Podgorna K, Blasiak E, Majeed N, Ogren S . Encapsulation of clozapine in polymeric nanocapsules and its biological effects. Colloids Surf B Biointerfaces. 2016; 140:342-352. DOI: 10.1016/j.colsurfb.2015.12.044. View

11.

Assegehegn G, Brito-de la Fuente E, Franco J, Gallegos C . The Importance of Understanding the Freezing Step and Its Impact on Freeze-Drying Process Performance. J Pharm Sci. 2018; 108(4):1378-1395. DOI: 10.1016/j.xphs.2018.11.039. View

12.

Yilgor P, Hasirci N, Hasirci V . Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A. 2009; 93(2):528-36. DOI: 10.1002/jbm.a.32520. View

13.

Prasetyanto E, Bertucci A, Septiadi D, Corradini R, Castro-Hartmann P, De Cola L . Breakable Hybrid Organosilica Nanocapsules for Protein Delivery. Angew Chem Int Ed Engl. 2015; 55(10):3323-7. DOI: 10.1002/anie.201508288. View

14.

Yuan Q, Shah J, Hein S, Misra R . Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. Acta Biomater. 2009; 6(3):1140-8. DOI: 10.1016/j.actbio.2009.08.027. View

15.

Ushirobira C, Afiune L, Pereira M, Cunha-Filho M, Gelfuso G, Gratieri T . Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus. Int J Biol Macromol. 2020; 151:56-61. DOI: 10.1016/j.ijbiomac.2020.02.143. View

16.

Almeida J, Chen A, Foster A, Drezek R . In vivo biodistribution of nanoparticles. Nanomedicine (Lond). 2011; 6(5):815-35. DOI: 10.2217/nnm.11.79. View

17.

Venturini C, Bruinsmann F, Contri R, Fonseca F, Frank L, DAmore C . Co-encapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma. Eur J Pharm Sci. 2015; 79:36-43. DOI: 10.1016/j.ejps.2015.08.016. View

18.

Trindade I, Pound-Lana G, Pereira D, de Oliveira L, Andrade M, Vilela J . Mechanisms of interaction of biodegradable polyester nanocapsules with non-phagocytic cells. Eur J Pharm Sci. 2018; 124:89-104. DOI: 10.1016/j.ejps.2018.08.024. View

19.

Blanco E, Shen H, Ferrari M . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015; 33(9):941-51. PMC: 4978509. DOI: 10.1038/nbt.3330. View

20.

Teixeira M, Alonso M, Pinto M, Barbosa C . Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm. 2005; 59(3):491-500. DOI: 10.1016/j.ejpb.2004.09.002. View